Clin2
NCT05766839Possibly a fitRecruiting

Potassium-lowering treatment for children under 12

Hyperkalemia

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests a medicine called patiromer, which helps lower high potassium levels in the blood. It is for children under 12 who have high potassium that needs treatment for at least a month.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
36 people
Ages
birth to 11 years
Study type
Interventional

Who can take part

  • Your child must be under 12 years old and have high potassium levels in the blood.
  • Your child must be able to take food and medicine regularly, including through a feeding tube if needed.
  • Your child must need treatment for high potassium for at least 28 days.
  • If your child takes certain heart or blood pressure medicines, they must be on a stable dose for at least 2 weeks before the study starts.
  • A parent or legal guardian must be available to help with study visits and giving the study medicine.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06256991Recruiting· Phase 4
Potassium management for kidney health

This study tests if careful potassium management can help people with chronic kidney disease (CKD) safely take higher doses of blood pressure medicines called ACE inhibitors or ARBs, which are known to protect the kidneys. You may be eligible if you have moderate to advanced CKD and are already on a moderate dose of one of these medications.

Groningen
NCT07251309Recruiting· Phase 3
Study of WS016 for treating high potassium levels

This trial tests a new drug called WS016 to lower high potassium levels in adults. High potassium can be dangerous for your heart, and this study aims to find out if WS016 is safe and effective.

Bengbu, Anhui
NCT06940414Recruiting
Study of high potassium in kidney disease patients in community

This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.

Shanghai, Shanghai Municipality
NCT06724991Enrolling by invitation
Lower vs standard insulin dose for high potassium in ER

This study compares a lower dose versus a standard dose of insulin and dextrose (sugar water) to treat moderately high potassium levels in emergency department patients. It aims to see if a lower dose works just as well with fewer side effects.

Kuala Lumpur
NCT07494266Recruiting
Potassium in plant-based diet for kidney patients

This trial tests whether a plant-based diet with more potassium is safe for people with advanced chronic kidney disease (CKD) compared to a plant-based diet with less potassium. It may help you understand how to manage your potassium levels while eating more plants.

Huddinge, Stockholm Län
NCT07772856Not yet recruiting
Relaxing potassium limits for hemodialysis patients

This study tests whether relaxing the usual potassium restrictions in your diet is safe and helpful for people on hemodialysis. It may allow you to eat more foods you enjoy while keeping your potassium at a safe level.

Toronto, Ontario

Hear when a new Hyperkalemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.